Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Cagnacci, Angelo ^a,c   Rovati, Lucio ^b   Zanni, Annalisa ^a   Malmusi, Stefania ^a   Facchinetti, Fabio ^a   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Rotta Research Laboratorium   (Italy)

^c Ist di Clin Ostet e Gincecologica   (Italy)

Author keywords

Cardiovascular risk; Circadian; Hypertension; Menopause

Indexed keywords

ESTRADIOL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032929001     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.4.h1355     Document Type: Article

References (55)

1. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect sphygmomanometry. Am. J. Hypertens. 5: 207-209, 1992.
2. Barrett-Connor, E. Heart disease in women. Fertil. Steril. 62: 127s-132s, 1994.
3. Benetos, A., M. Safar, A. Rudnichi, H. Smulyan, J. L. Richard, P. Ducimetiere, and L. Guize. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population. Hypertension 30: 1410-1415, 1997.
4. Cagnacci, A., S. Arangino, M. Angiolucci, E. Maschio, and G. B. Melis. Influences of melatonin administration on the circulation of women. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R335-R338, 1998.
5. Cagnacci, A., J. A. Elliott, and S. S. C. Yen. Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J. Clin. Endocrinol. Metab. 75: 447-452, 1992.
6. Cagnacci, A., G. B. Melis, R. Soldani, A. M. Paoletti, M. Gambacciani, A. Spinetti, and P. Fioretti. Neuroendocrine and clinical effects of transdermal 17 β-estradiol in postmenopausal women. Maturitas 13: 283-296, 1991.
7. Cagnacci, A., R. Soldani, P. L. Carriero, A. M. Paoletti, P. Fioretti, and G. B. Melis. Effects of low doses of transdermal 17 β-estradiol on carbohydrate metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 74: 1396-1400, 1992.
8. Cagnacci, A., R. Soldani, and S. S. C. Yen. Melatonin enhances cortisol levels in aged women: reversible by estrogens. J. Pineal Res. 22: 81-88, 1997.
9. Cagnacci, A., F. Tuveri, R. Cirillo, A. M. Setteneri, G. B. Melis, and A. Volpe. The effect of transdermal 17-β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration. Maturitas 28: 163-167, 1997.
10. Collins, P. Vascular aspects of estrogen. Maturitas 23: 217-26, 1996.
11. Ettinger, B., G. D. Friedman, T. Bush, and C. P. Quesenberry. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol. 87: 6-12, 1996.
12. Final results of the systolic hypertension in the elderly program (SHEP). Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 265: 3255-3264, 1991.
13. Franklin, S. S., and M. A. Weber. Measuring hypertensive cardiovascular risk: the vascular overload concept. Am. Heart J. 128: 793-803, 1994.
14. Friedewald, W. T., R. I. Levy, and D. S. Fredrikson. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502, 1972.
15. Gillum, R. F., H. L. Taylor, J. Brozek, P. Polansky, and H. Blackburn. Indices of obesity and blood pressure in young men followed 32 years. J. Chronic. Dis. 35: 211-219, 1982.
16. Green, A., and C. Bain. Epidemiological overview of oestrogen replacement and cardiovascular disease. Baillieres Clin. Endocrinol Metab. 7: 95-112, 1993.
17. Grodstein, F., M. J. Stampfer, G. A. Colditz, W. C. Willet, J. E. Manson, M. Joffe, B. Rosner, C. Fuchs, S. E. Hankinson, D. J. Hunter, C. H. Hennekens, and F. E. Speizer. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336: 1769-1775, 1997.
18. Guagnano, M. T., D. Merlitti, R. Murri, V. P. Palitti, and S. Sensi. Ambulatory blood pressure monitoring in evaluating the relationship between obesity and blood pressure. J. Hum. Hypertens. 8: 245-250, 1994.
19. Hammond, C. B., F. R. Jelovsek, K. L. Lee, W. T. Creasman, and R. T. Parker. Effects of long-term estrogen replacement therapy. Am. J. Obstet. Gynecol. 133: 525-536, 1979.
20. Hassager, C., and C. Christiansen. Blood pressure during oestrogen/progestogen substitution therapy in healthy postmenopausal women. Maturitas 9: 315-323, 1988.
21. Hassager, C., B. J. Riis, V. Strom, T. T. Guyene, and C. Christiansen. The long term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76: 753-758, 1987.
22. Heintz, B., C. Schmauder, K. Witte, I. Breuer, K. Baltzer, H. G. Sieberth, and B. Lemmer. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives. J. Hypertens. 14: 333-339, 1996.
23. Kafonic, S. D. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. Drugs 47: 16-24, 1994.
24. Littler, W. A. Sleep and blood pressure: further observations. Am. Heart J. 97: 35-37, 1979.
25. Littler, W. A., A. J. Honour, B. D. Carter, and P. Sleight. Sleep and blood pressure. Br. Med. J. 3: 346-348, 1975.
26. Luotola, H. Blood pressure and hemodynamics in postmenopausal women during estradiol-17β-substitution. Ann. Clin. Res. 15: 1-121, 1983.
27. Mashchak, C. A., and R. A. Lobo. Estrogen replacement therapy and hypertension. J. Reprod. Med. 30, Suppl. 10: 805-808, 1983.
28. Myers, M. G. Twenty-four-hour blood pressure control: a brief review of aspects of target-organ protection. J. Hypertens. Suppl. 14: S7-S10, 1996.
29. Mercuro, G., C. Balloi, G. De Candia, M. G. Panzuto, S. Zoncu, A. Cagnacci, G. B. Melis, and A. Cherchi. Effects of transdermal estrogen administration on peripheral vascular responsiveness in menopausal women. Int. J. Angiol. 6: 237-240, 1997.
30. Mercuro, G., S. Zoncu, I. Pilia, A. Lao, G. B. Melis, and A. Cherchi. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am. J. Cardiol. 80: 652-654, 1997.
31. Nabulsi, A. A., A. R. Folsom, A. White, W. Patsch, G. Heis, K. K. Wu, and M. Szelo. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N. Engl. J. Med. 328: 1069-1075, 1993.
32. National Cholesterol Education Program. Summary of second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholsterol in adults (adult treatment panel II). JAMA 269: 3015-3023, 1993.
33. Nelson, W., Y. L. Tong, J.-K. Lee, and F. Halberg. Methods for cosinor-rhythmometry. Chronobiologia 6: 305-323, 1979.
34. Pedulla, M., R. Silvestri, A. Lasco, G. Mento, B. Lanuzza, L. Sofia, and N. Frisina. Sleep structure in essential hypertensive patients: differences between dippers and non dippers. Blood Press. 4: 232-237, 1995.
35. Regensteiner, J. G., W. R. Hiatt, R. L. Byyny, C. K. Pickett, D. Woodard, C. Grindlay, and L. Moore. Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women. J. Clin. Pharmacol. 31: 543-548, 1991.
36. Rich-Edwards, J. W., J. E. Manson, C. H. Hennerens, and J. C. Buring. The primary prevention of coronary heart disease in women. N. Engl. J. Med. 332: 1758-1766, 1995.
37. Rubin, P., T. F. Blaschke, and C. Guilleminault. Effect of naloxone, a specific opioid inhibitor, on blood pressure fall during sleep. Circulation 63: 117-121, 1981.
38. Saltzberg, S., and J. A. Stroh. Isolated systolic hypertension in the elderly: pathophysiology and treatment. Med. Clin. North Am. 72: 523-547, 1988.
39. Samsioe, G. Hormone replacement therapy and cardiovascular disease. J. Cardiovasc. Pharmacol. 28: S51-S57, 1996.
40. Sands, R. H., J. W. W. Studd, D. Crook, J. B. Warren, J. Cruickshank, and A. Coats. The effect of estrogen on blood pressure in hypertensive postmenopausal women. Menopause 4: 115-119, 1997.
41. Schmeider, R. E., J. K. Rockstroh, F. Aepfelbacher, B. Schulze, and F. H. Messerli. Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am. J. Hypertens. 8:1160-1166, 1995.
42. Sindrup, J. H., J. Kastrup, H. Christiansen, and B. Jorgensen. Nocturnal variations in peripheral blood flow, systemic blood pressure, and heart rate in humans. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H982-H988, 1991.
43. Skafar, D. F., R. Xu, J. Morales, J. Ram, and J. R. Sowers. Female sex hormones and cardiovascular disease in women. J. Clin. Endocrinol. Metab. 82: 3913-3918, 1997.
44. Staessen, J. A., L. Bieniaszewski, I. Brosens, and R. Fagard. The epidemiology of menopause and associated cardiovascular disease. In: Hypertension After Menopause, edited by M. Stimpel and A. Zanchetti. Berlin: de Gruyter, 1997, p. 21-30.
45. Staessen, J. A., C. J. Bulpitt, R. Fagard, P. Lijnen, and A. Amery. The influence of menopause on blood pressure. J. Hum. Hypertens. 3: 427-433, 1989.
46. Stergiou, G. S., J. S. Malakos, A. S. Zourbaki, A. D. Achimastos, and T. D. Mountokalakis. Blood pressure during siesta: effect on 24-h ambulatory blood pressure profiles analysis. J. Hum. Hypertens. 11: 125-131, 1997.
47. Streitberg, B., W. Meyer-Sabellek, and P. Baumgart. Statistical analysis of circadian blood pressure recordings in controlled clinical trials. J. Hypertens. Suppl. 7: S11-S17, 1989.
48. Sudhir, K., M. D. Esler, G. L. Jennings, and P. A. Komesaroff. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 30: 1538-1543, 1997.
49. Sullivan, J. Hormone replacement therapy and cardiovascular disease: the human model. Br. J. Obstet. Gynaecol. 103, Suppl. 13: 59-67, 1996.
50. Task force on oral contraceptive, WHO special programme of research, development, and research training in human reproduction. The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: comparisons with IUD. Contraception 50: 129-145, 1989.
51. The Writing Group for the PEPI Trial. Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273: 199-208, 1995.
52. Verdecchia, P., G. Schillaci, C. Borgioni, A. Ciucci, N. Sacchi, M. Battistelli, M. Guerrieri, E. Comparato, and C. Porcellati. Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension. Dippers and peakers. Am. J. Hypertens. 8: 193-196, 1995.
53. Verdecchia, P., G. Schillaci, C. Gatteschi, I. Zampi, M. Battistelli, C. Bartoccini, and C. Porcellati. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 88: 986-992, 1993.
54. Wieseman, L. R., and D. McTavish. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women. Drugs Aging 4: 238-256, 1994.
55. Wren, B. G., and A. D. Routledge. The effect of type and dose of oestrogen on the blood pressure of post-menopausal women. Maturitas 5: 135-142, 1983.